Chicago Capital Management’s Akcea Therapeutics Inc AKCA Stock Holding History

Chicago Capital Management’s Portfolio AKCA Stock Details AKCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-37,931	Closed	-$688K	–	26
2020 Q3	$688K	Buy	+37,931	New	+$538K	0.66%	12

Chicago Capital Management's AKCA Position: Q4 2020 in Review

Chicago Capital Management sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 37,931 shares — an estimated $688K sold.

Chicago Capital Management first reported a position in AKCA in Q3 2020 and held it in 1 quarter. The position peaked at $688K in Q3 2020. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

Chicago Capital Management reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
Chicago Capital Management sold 37,931 Akcea Therapeutics Inc shares in Q4 2020, an estimated $688K.
Chicago Capital Management first reported a position in Akcea Therapeutics Inc in Q3 2020 and held it in 1 quarter.
Chicago Capital Management's Akcea Therapeutics Inc position peaked at $688K in Q3 2020.
0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Chicago Capital Management's 13F filing for Q4 2020, filed 10 Feb 2021.